Table 1

Medical data on children with chronic lung disease (CLD) and controls in the neonatal period and at 5.5 years of age: analysis of group differences

CLD children (n=32)Control children (n=28)p Values
Values are mean (SD), number, or median [quartile range]. The group of children with CLD was made up of 13 with grade I–II and 19 with grade III.
*Medical risk factors.
SGA, Small for gestational age; BW, body weight; ROP, retinopathy of prematurity; ANOVA, analysis of variance.
Neonatal period
    Gestational age at birth (weeks)*25 [2]27 [[3]]0.004 (Kruskal-Wallis ANOVA)
    Birth weight*809 [206]852 [[370]]0.22 (Kruskal-Wallis ANOVA)
    SGA*04
    BW ratio*0.97 [0.15]0.93 [[0.2]]0.10 (Kruskal-Wallis ANOVA)
    No ROP870.77 (χ2 with Yates correction)
    ROP I–II*15170.42 (χ2 with Yates correction)
    ROP III+ cryotherapy*940.33 (χ2 with Yates correction)
5.5 years
    Body weight (kg)18.7 (2.9)19.0 (3.0)0.70 (Student’s t test)
    Length (cm)112.8 (5.2)112.2 (5.3)0.66 (Student’s t test)
    Maternal education, level 0–65.0 [3.0]4.5 [2.5]0.70 (Kruskal-Wallis ANOVA)
    Correction (glasses/lenses)*9100.72 (χ2 with Yates correction)
    Hand dominance*
        Right26200.55 (χ2 with Yates correction)
        Left470.36 (χ2 with Yates correction)
        Shifting21
    Asthma - medication*620.35 (χ2 with Yates correction)